{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:51:42Z","timestamp":1791640302764,"version":"4.3.4"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T00:00:00Z","timestamp":1570492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["101696\/Z\/13\/Z"],"award-info":[{"award-number":["101696\/Z\/13\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BMA Foundation"},{"name":"National Organisation for Rare Disorders"},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["104079\/Z\/14\/Z"],"award-info":[{"award-number":["104079\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BMA Research Grants- Vera Down"},{"DOI":"10.13039\/501100000295","name":"Epilepsy Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oxford Biomedical Research Centre"},{"name":"Nuffield Department of Clinical Neurosciences"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000295","name":"Epilepsy Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000295","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:p>Immunoglobulin G autoantibodies to glycine receptors are found in many patients with progressive encephalomyelitis with rigidity and myoclonus (PERM). Crisp et al. show that purified patient IgGs disrupt inhibitory neurotransmission in cultured motoneurons, and provide evidence for direct antagonistic actions on glycine receptors.<\/jats:p>","DOI":"10.1093\/brain\/awz297","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T07:47:39Z","timestamp":1568015259000},"page":"3398-3410","source":"Crossref","is-referenced-by-count":86,"title":["Glycine receptor autoantibodies disrupt inhibitory neurotransmission"],"prefix":"10.1093","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-7775","authenticated-orcid":false,"given":"Sarah J","family":"Crisp","sequence":"first","affiliation":[{"name":"UCL Institute of Neurology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L","family":"Dixon","sequence":"additional","affiliation":[{"name":"UCL Institute of Neurology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Chabrol","sequence":"additional","affiliation":[{"name":"UCL Institute of Neurology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-9748","authenticated-orcid":false,"given":"Sarosh R","family":"Irani","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Isabel","family":"Leite","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Leschziner","sequence":"additional","affiliation":[{"name":"Department of Neurology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"},{"name":"Department of Clinical Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J","family":"Slaght","sequence":"additional","affiliation":[{"name":"Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[{"name":"UCL Institute of Neurology, University College London, London, UK"},{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6696-3545","authenticated-orcid":false,"given":"Dimitri M","family":"Kullmann","sequence":"additional","affiliation":[{"name":"UCL Institute of Neurology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,8]]},"reference":[{"key":"2019121022382460700_awz297-B1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jnnp.65.5.633","article-title":"Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity","volume":"65","author":"Barker","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2019121022382460700_awz297-B2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1756-6606-7-2","article-title":"The impact of human hyperekplexia mutations on glycine receptor structure and function","volume":"7","author":"Bode","year":"2014","journal-title":"Mol Brain"},{"key":"2019121022382460700_awz297-B3","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","article-title":"Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy","volume":"54","author":"Brenner","year":"2013","journal-title":"Epilepsia"},{"key":"2019121022382460700_awz297-B4","doi-asserted-by":"crossref","first-page":"28975","DOI":"10.1074\/jbc.M112.372094","article-title":"Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease","volume":"287","author":"Carta","year":"2012","journal-title":"J Biol Chem"},{"key":"2019121022382460700_awz297-B5","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonzalez","year":"2014","journal-title":"Brain"},{"key":"2019121022382460700_awz297-B6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/WCO.0000000000000450","article-title":"Redefining progressive encephalomyelitis with rigidity and myoclonus after the discovery of antibodies to glycine receptors","volume":"30","author":"Crisp","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"2019121022382460700_awz297-B7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrn.2015.27","article-title":"Autoimmune synaptopathies","volume":"17","author":"Crisp","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"2019121022382460700_awz297-B8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol Rev"},{"key":"2019121022382460700_awz297-B9","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","article-title":"Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation","volume":"298","author":"Drachman","year":"1978","journal-title":"N Engl J Med"},{"key":"2019121022382460700_awz297-B10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/epi.12528","article-title":"Investigation of neuronal autoantibodies in two different focal epilepsy syndromes","volume":"55","author":"Ekizoglu","year":"2014","journal-title":"Epilepsia"},{"key":"2019121022382460700_awz297-B11","first-page":"319","article-title":"Purification and culture of spinal motor neurons from rat embryos","volume":"2013","author":"Graber","year":"2013","journal-title":"Cold Spring Harb Protoc"},{"key":"2019121022382460700_awz297-B12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuron.2018.07.048","article-title":"Human autoantibodies against the AMPA receptor subunit GluA2 induce receptor reorganization and memory dysfunction","volume":"100","author":"Haselmann","year":"2018","journal-title":"Neuron"},{"key":"2019121022382460700_awz297-B13","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1073\/pnas.74.7.3090","article-title":"Modulation of acetylcholine receptor by antibody against the receptor","volume":"74","author":"Heinemann","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019121022382460700_awz297-B14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0896-6273(89)90258-4","article-title":"Primary cultures of mouse spinal cord express the neonatal isoform of the inhibitory glycine receptor","volume":"3","author":"Hoch","year":"1989","journal-title":"Neuron"},{"key":"2019121022382460700_awz297-B15","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"2019121022382460700_awz297-B16","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"key":"2019121022382460700_awz297-B17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.neuron.2008.02.031","article-title":"Rapid synaptic scaling induced by changes in postsynaptic firing","volume":"57","author":"Ibata","year":"2008","journal-title":"Neuron"},{"key":"2019121022382460700_awz297-B18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1113\/jphysiol.2003.041053","article-title":"Activation of presynaptic glycine receptors facilitates glycine release from presynaptic terminals synapsing onto rat spinal sacral dorsal commissural nucleus neurons","volume":"550","author":"Jeong","year":"2003","journal-title":"J Physiol"},{"key":"2019121022382460700_awz297-B19","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1212\/NXI.0000000000000386","article-title":"Frequencies of neuronal autoantibodies in healthy controls: estimation of disease specificity","volume":"4","author":"Lang","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2019121022382460700_awz297-B20","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1002\/j.1460-2075.1994.tb06742.x","article-title":"Decreased agonist affinity and chloride conductance of mutant glycine receptors associated with human hereditary hyperekplexia","volume":"13","author":"Langosch","year":"1994","journal-title":"EMBO J"},{"key":"2019121022382460700_awz297-B21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuropharm.2008.07.034","article-title":"Native glycine receptor subtypes and their physiological roles","volume":"56","author":"Lynch","year":"2009","journal-title":"Neuropharmacology"},{"key":"2019121022382460700_awz297-B22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamaneurol.2016.0133","article-title":"Clinical and immunologic investigations in patients with stiff-person spectrum disorder","volume":"73","author":"Martinez-Hernandez","year":"2016","journal-title":"JAMA Neurol"},{"key":"2019121022382460700_awz297-B23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2014.3602","article-title":"Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor alpha1 subunit in patients with isolated optic neuritis","volume":"72","author":"Martinez-Hernandez","year":"2015","journal-title":"JAMA Neurol"},{"key":"2019121022382460700_awz297-B24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: clinical course, treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch Neurol"},{"key":"2019121022382460700_awz297-B25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.10279","article-title":"Stiff man syndrome and related conditions","volume":"17","author":"Meinck","year":"2002","journal-title":"Mov Disord"},{"key":"2019121022382460700_awz297-B26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/epi4.12067","article-title":"Pathogenic potential of antibodies to the GABAB receptor","volume":"2","author":"Nibber","year":"2017","journal-title":"Epilepsia Open"},{"key":"2019121022382460700_awz297-B27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0896-6273(00)80624-8","article-title":"Activity-dependent modulation of synaptic AMPA receptor accumulation","volume":"21","author":"O'Brien","year":"1998","journal-title":"Neuron"},{"key":"2019121022382460700_awz297-B28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.24293","article-title":"Cellular plasticity induced by anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies","volume":"77","author":"Peng","year":"2015","journal-title":"Ann Neurol"},{"key":"2019121022382460700_awz297-B29","first-page":"3144","article-title":"LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory","volume":"141","author":"Petit-Pedrol","year":"2018","journal-title":"Brain"},{"key":"2019121022382460700_awz297-B30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planaguma","year":"2015","journal-title":"Brain"},{"key":"2019121022382460700_awz297-B31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/mcne.2001.1074","article-title":"Strychnine-blocked glycine receptor is removed from synapses by a shift in insertion\/degradation equilibrium","volume":"19","author":"Rasmussen","year":"2002","journal-title":"Mol Cell Neurosci"},{"key":"2019121022382460700_awz297-B32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng1814","article-title":"Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease","volume":"38","author":"Rees","year":"2006","journal-title":"Nat Genet"},{"key":"2019121022382460700_awz297-B33","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1172\/JCI119048","article-title":"Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function","volume":"98","author":"Riemersma","year":"1996","journal-title":"J Clin Invest"},{"key":"2019121022382460700_awz297-B34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ng1293-351","article-title":"Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia","volume":"5","author":"Shiang","year":"1993","journal-title":"Nat Genet"},{"key":"2019121022382460700_awz297-B35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/practneurol-2013-000511","article-title":"Glycine receptor antibody mediated progressive encephalomyelitis with rigidity and myoclonus (PERM): a rare but treatable neurological syndrome","volume":"14","author":"Stern","year":"2014","journal-title":"Pract Neurol"},{"key":"2019121022382460700_awz297-B36","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/jnnp.43.9.836","article-title":"Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG","volume":"43","author":"Toyka","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2019121022382460700_awz297-B37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0006-8993(00)01954-5","article-title":"Motor neurons are rich in non-phosphorylated neurofilaments: cross-species comparison and alterations in ALS","volume":"861","author":"Tsang","year":"2000","journal-title":"Brain Res"},{"key":"2019121022382460700_awz297-B38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/35079084","article-title":"Presynaptic glycine receptors enhance transmitter release at a mammalian central synapse","volume":"411","author":"Turecek","year":"2001","journal-title":"Nature"},{"key":"2019121022382460700_awz297-B39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2013.08.034","article-title":"Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica","volume":"335","author":"Woodhall","year":"2013","journal-title":"J Neurol Sci"},{"key":"2019121022382460700_awz297-B40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nn.3615","article-title":"Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease","volume":"17","author":"Xiong","year":"2014","journal-title":"Nat Neurosci"},{"key":"2019121022382460700_awz297-B41","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1212\/NXI.0000000000000016","article-title":"Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy","volume":"1","author":"Zuliani","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/142\/11\/3398\/30329989\/awz297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/142\/11\/3398\/30329989\/awz297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T22:40:53Z","timestamp":1576017653000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/142\/11\/3398\/5583666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,8]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,10,8]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awz297","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,10,8]]}}}